This Article Full Text (OnlineFirst PDF) All Versions of this Article: 1087057108317145v1 13/5/378    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Zhang, X. D. Articles by Ferrer, M. Search for Related Content PubMed PubMed Citation Articles by Zhang, X. D. Articles by Ferrer, M. Pubmed/NCBI databases Substance via MeSH Social Bookmarking                         What's this?

Integrating Experimental and Analytic Approaches to Improve Data Quality in Genome-wide RNAi Screens

Merck Research Laboratories

^* To whom correspondence should be addressed. E-mail: xiaohua_zhang{at}merck.com.

	Abstract

RNA interference (RNAi) not only plays an important role in drug discovery but can also be developed directly into drugs. RNAi high-throughput screening (HTS) biotechnology allows us to conduct genome-wide RNAi research. A central challenge in genome-wide RNAi research is to integrate both experimental and computational approaches to obtain high quality RNAi HTS assays. Based on our daily practice in RNAi HTS experiments, we propose the implementation of 3 experimental and analytic processes to improve the quality of data from RNAi HTS biotechnology: (1) select effective biological controls; (2) adopt appropriate plate designs to display and/or adjust for systematic errors of measurement; and (3) use effective analytic metrics to assess data quality. The applications in 5 real RNAi HTS experiments demonstrate the effectiveness of integrating these processes to improve data quality. Due to the effectiveness in improving data quality in RNAi HTS experiments, the methods and guidelines contained in the 3 experimental and analytic processes are likely to have broad utility in genome-wide RNAi research. (Journal of Biomolecular Screening XXXX:xx-xx)

First published on May 14, 2008, doi:10.1177/1087057108317145

Journal of Biomolecular Screening 2008;13:378.

A more recent version of this article appeared on June 1, 2008


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				X. D. Zhang and J. F. Heyse Determination of sample size in genome-scale RNAi screens Bioinformatics, April 1, 2009; 25(7): 841 - 844. [Abstract] [Full Text] [PDF]

				X. D. Zhang, S. D. Marine, and M. Ferrer Error Rates and Powers in Genome-Scale RNAi Screens J Biomol Screen, March 1, 2009; 14(3): 230 - 238. [Abstract] [PDF]

				I. Coma, L. Clark, E. Diez, G. Harper, J. Herranz, G. Hofmann, M. Lennon, N. Richmond, M. Valmaseda, and R. Macarron Process Validation and Screen Reproducibility in High-Throughput Screening J Biomol Screen, January 1, 2009; 14(1): 66 - 76. [Abstract] [PDF]

				X. D. Zhang, P. F. Kuan, M. Ferrer, X. Shu, Y. C. Liu, A. T. Gates, P. Kunapuli, E. M. Stec, M. Xu, S. D. Marine, et al. Hit selection with false discovery rate control in genome-scale RNAi screens Nucleic Acids Res., August 1, 2008; 36(14): 4667 - 4679. [Abstract] [Full Text] [PDF]